Tatsuaki Tagami

3.1k citations
87 papers · 2.5k indexed · h-index 29

Tatsuaki Tagami

85 papers receiving 2.5k citations

Peers

Tatsuaki Tagami
Comparison fields: 5 of 135
  • Pharmaceutical Science 470
  • Biomaterials 929
  • Automotive Engineering 397
  • Biomedical Engineering 1.3k
  • Molecular Medicine 127
Replace Anna Maria Piras with:
Anna Maria Piras Italy
Christian Wischke Germany
Pankaj Karande United States
Yury Rochev Ireland
Pierre P. D. Kondiah South Africa
Jonathan Goole Belgium
Muhammad Sohail Arshad Pakistan
Hongfan Sun China
Joonyoung Park South Korea
Nhiem Tran Australia
Tatsuaki Tagami relative to Anna Maria Piras Italy Anna Maria Piras's profile →
Citations per field
00.5×2.6×
Anna Maria Piras · 1×
Citations per year

Countries citing papers authored by Tatsuaki Tagami

Since Specialization
Citations

This map shows the geographic impact of Tatsuaki Tagami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuaki Tagami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuaki Tagami more than expected).

Fields of papers citing papers by Tatsuaki Tagami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuaki Tagami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuaki Tagami. The network helps show where Tatsuaki Tagami may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tatsuaki Tagami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tatsuaki Tagami Line = papers co-authored together Tatsuaki Tagami links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 202410
3 20244
4 20233
5 20231
6 202311
7 20234
8 202098
9 201958
10 201851
11 201832
12 201620
13 201520
14 201421
15 201347
16 20129
17 2011125
18 2011131
19 200820
20 200628

About Tatsuaki Tagami

Tatsuaki Tagami is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 87 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (22 papers), RNA Interference and Gene Delivery (18 papers), Advanced Drug Delivery Systems (16 papers), Drug Solubulity and Delivery Systems (15 papers), Nanoplatforms for cancer theranostics (14 papers), Inhalation and Respiratory Drug Delivery (14 papers), 3D Printing in Biomedical Research (12 papers) and Advanced biosensing and bioanalysis techniques (11 papers). The work is most often cited by research in Pharmaceutical Science (470 citations), Biomaterials (929 citations) and Automotive Engineering (397 citations). Tatsuaki Tagami has collaborated with scholars based in Japan, Canada and Brazil. Frequent co-authors include Tetsuya Ozeki, Shyh‐Dar Li, Mark J. Ernsting, Tatsuhiro Ishida, Hiroshi Kiwada, Kaori Fukushige, Naomi Hayashi, Jonathan P. May, Warren D. Foltz and Kazuya Nakamura. Their work appears in journals such as Biomaterials, Advanced Drug Delivery Reviews and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026